CliffBio
small molecule

SODIUM CHLORIDE 0.9%

SODIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyNexus Labs →See this company's full patent-cliff portfolio

Drug detail

Brand nameSODIUM CHLORIDE 0.9%
Active ingredientSODIUM CHLORIDE
Strength180MG/20ML (9MG/ML)
Dosage formSOLUTION
RouteINJECTION
ModalitySmall molecule
FDA approvalAugust 2023
Marketing statusRX

More from Nexus Labs

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

SODIUM CHLORIDE 0.9% patent cliff — loss of exclusivity — | CliffBio